HSV-2 Vaccine Vector to Encode Multiple HIV T-cell Epitopes

Lynda Morrison of St. Louis University in the U.S. will develop a vaccine vector based on a prototype vaccine for herpes simplex virus 2 (HSV-2) that encodes multiple CD8 T cell epitopes from HIV proteins, and test its ability to stimulate a robust CD8 T cell response against HIV.